Oramed COO, CBO Joshua Hexter disposes of USD 135,330 in common shares

• Oramed Pharmaceuticals COO and CBO Joshua Hexter sold 30,000 common shares on Oct. 1, 2026.
• Sale priced at USD 4.511 per share on a weighted-average basis.
• Post-transaction holding totaled 1,328,130 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oramed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106530), on October 02, 2026, and is solely responsible for the information contained therein.